Press

Lawrence O. Gostin

Drugmakers Are ‘Throwing the Kitchen Sink’ to Halt Medicare Price Negotiations

S. Sean Tu

After Pushback, J&J Allows Generics of Its TB Drug

Lawrence O. Gostin

HHS Gets Financial Weapon to Crack Down on Contract, Grant Fraud

Zachary L. Baron

Pharma Battling Legal Precedent in Medicare Drug Price Lawsuits

Zachary L. Baron

The Health 202: Big Pharma has a new strategy to fight drug negotiation

Zachary L. Baron

Big Pharma’s legal fight to stop cheaper Medicare drugs, explained

Lawrence O. Gostin

The fight against cancer faces daunting new challenge: debt politics

Drugmakers want to stop Medicare from negotiating prices. Here’s what you should know

Lawrence O. Gostin

Pact allows ACA to require preventive services amid legal battle

S. Sean Tu

WVU research shows how much pharmaceutical companies are capitalizing on rare drug incentives

Zachary L. Baron

Merck fires opening legal salvo in Medicare drug pricing negotiations

Andrew J. Twinamatsiko

Appeals court to weigh fate of ACA preventive care requirement

Lawrence O. Gostin

US Wants Another Shot at Gilead’s HIV-Prevention Drug Royalties

Andrew J. Twinamatsiko

The Abortion Pill Fight Heads Back to Court – What You Need to Know

S. Sean Tu

U.S. Supreme Court declines bid by Teva to hear ‘skinny labeling’ case with implications for generic drug access

Lawrence O. Gostin

Big Pharma, US Research Pacts in Flux After Gilead’s Trial Win

S. Sean Tu

Do Orphan Drugs Really Need Development Incentives?

Lawrence O. Gostin

Fact Check: ‘Quarantine camps’ takes NY public health rule too far

Regina LaBelle

In Jails and Prisons, the White House Sees a Chance to Curtail Opioid Overdoses

Drugmakers take sides in Amgen, Regeneron fight over antibody patents

Lawrence O. Gostin

US takes Texas abortion pill case to Supreme Court

Lawrence O. Gostin

U.S. to ask Supreme Court to restore full access to abortion pill